Results 331 to 340 of about 342,150 (384)

Clinical outcomes with first-line tislelizumab plus lenvatinib in unresectable hepatocellular carcinoma: a retrospective analysis. [PDF]

PeerJ
Lin J, Zhou Q, Yao Z, Wang Q, Xu S, Xiong Z, Dang X, Liang H, Liu B.   +8 more
europepmc   +1 more source

Preventing vertical transmission of hepatitis B in sub-Saharan Africa: protocol for a systematic review and meta-analysis on vaccination uptake and determinants among pregnant women. [PDF]

BMJ Open
Afolabi IB, Phillips JC, El-Chaâr D, Bainbridge SA, Phillips KP.   +4 more
europepmc   +1 more source

IL-21 attenuates liver inflammation by enhancing myeloid-derived suppressor cells immunosuppressive function in chronic HBV infection. [PDF]

J Transl Med
Li X, Jin Z, Pan M, Dong Z, Chen J, Liu Z, Chen H, Ye G, Zhong S, He W, Tang L, Rao G, Li Y.   +12 more
europepmc   +1 more source

Prevalence of HBV and HCV Infections and Associated Risk Factors in Addict Prisoners

, 2006
Amir Javadi, Majid Avijgan, Masoud Hafizi   +2 more
openalex   +1 more source

A retrospective study of preoperative HBsAg levels predicting recurrence after curative resection in patients with HBV-associated hepatocellular carcinoma. [PDF]

Medicine (Baltimore)
Xu R, Su Q, Liao X, Zhu G, Su H, Han C, Wei Y, Zhou X, Ye X, Peng T.   +9 more
europepmc   +1 more source

The interferon-inducible MxB large GTPase attenuates hepatitis B virus replication by activating the RIG-I innate immunity signaling pathway. [PDF]

Sci Rep
Onuki M, Inoue J, Doi K, Ninomiya M, Sano A, Tsuruoka M, Sato K, Sawahashi S, Ouchi K, Watanabe K, McNiven MA, Masamune A.   +11 more
europepmc   +1 more source